losartan has been researched along with Kidney, Polycystic in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Awazu, M | 1 |
Yamada, M | 1 |
Asada, N | 1 |
Hashiguchi, A | 1 |
Kosaki, K | 1 |
Matsumura, K | 1 |
Keith, DS | 1 |
Torres, VE | 1 |
Johnson, CM | 1 |
Holley, KE | 1 |
2 other studies available for losartan and Kidney, Polycystic
Article | Year |
---|---|
A girl with a mutation of the ciliary gene CC2D2A presenting with FSGS and nephronophthisis.
Topics: Child; Child, Preschool; Cytoskeletal Proteins; Female; Fibrosis; Glomerulosclerosis, Focal Segmenta | 2022 |
Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compoun | 1994 |